Physician profile
Eric Robert Wood
NPI 1013940956
$1,364.84
in general payments reported to CMS, 2019-2025
21 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $266 · 2023: $410 · 2024: $232 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $236.84 | 2021-2023 | Xarelto |
| Abbvie INC. | $223.20 | 2021-2025 | |
| Reprise Biomedical, INC. | $122.84 | 2025 | Miro3d |
| Organogenesis INC. | $98.70 | 2023-2025 | Puraply Wound Matrix, Puraply, Cygnus Matrix |
| Kci USA, INC. | $98.53 | 2023 | V.A.C.Instill, Prevena, V.A.C. Dermatac |
| Smith+Nephew, INC. | $90.97 | 2024-2025 | Collagenase Santyl |
| Reapplix INC. | $68.65 | 2024 | 3c Patch Kit - Box |
| Next Science LLC | $55.65 | 2023 | Blastx, Xperience, Surgx |
| Endologix LLC | $50.49 | 2021 | |
| Polymedics Innovations INC. | $43.53 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.09 | 2022-2023 | Gattex |
| Kerecis Limited | $38.07 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $36.11 | 2024-2025 | Activ.A.C., V.A.C. Granufoam, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $32.92 | 2024 | Tcc-Ez |
| Avinger INC. | $31.23 | 2023 | Pantheris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $21.30 | 2023 | |
| Silk Road Medical, INC. | $20.19 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.14 | 2024 | Nuzyra |
| Tactile Systems Technology INC | $14.87 | 2023 | Entre Plus, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $12.25 | 2022 | |
| Triad Life Sciences INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.